TRXB

10.3156.12%
JS

Joel S. Marcus

Founder & Executive Chairman

Mr. Joel S. Marcus, J.D., CPA, is an Independent Director at TRex Bio from November 2024. He joined TRex Bio, Inc. since November 2024. He is Director of Biohealth Innovation. He was a Director at IgGenix Inc. since September 2022 until 2024 and serves as Executive Chairman, Head & Founder at Alexandria Venture Investments, LLC. He serves as Director of Santa Maria Biotherapeutics, Inc. He served as Director at Korro Bio Inc. He served as the Director at Équilibre BioPharmaceuticals Corp. until 2022. He served as CEO & Chairman at the firm. He served as an Independent Director at MeiraGTx Holdings plc since June 2015 until June 27, 2022. Mr. Marcus founded Alexandria Real Estate Equities, Inc. in 1994 and also has been its Founder & Executive Chairman since May 2007. Mr. Marcus served as Independent Director of Applied Therapeutics Inc. since January 2017 until December 6, 2024. He has been a Director of AltPep Corporation since December 2020. He had been the Chief Executive Officer of Alexandria Real Estate Equities, Inc. from March 1997 until April 23, 2018. Mr. Marcus has been Executive Director of Alexandria Real Estate Equities, Inc. since 1994 and Yumanity Therapeutics, Inc. since February 10, 2016. Earlier, he was the Chief Executive Officer and Chairman of the firm. He serves as an Advisor of Emerging Technology Partners, LLC. He is Director of The Navy SEAL Foundation since February 1, 2018. He co-founded Alexandria in 1994 as a garage startup and has led its growth into an S&P 500 company. Mr. Marcus has built Alexandria's unique business model around four business verticals - real estate, venture investments, thought leadership and corporate social responsibility. He has been involved with the formation, financing and operations of companies. Mr. Marcus has extensive expertise, experience and contacts in the life sciences and real estate industries. He is highly experienced in real estate, finance and capital market matters, venture capital, mergers and acquisitions. Mr. Marcus had an extensive legal career specializing in corporate finance and capital markets, venture capital and mergers and acquisitions, with expertise in the biopharmaceutical industry. He was a co-Founder of Research!America. He co-founded the Alexandria Summit in 2011. Mr. Marcus specialized in corporate finance and capital markets, venture capital and mergers and acquisitions with special expertise in the biopharmaceutical industry. From 1986 to 1994, he was a Partner at the law firm of Brobeck, Phleger & Harrison, LLP, specializing in corporate finance and capital markets, venture capital and mergers & acquisitions, in the bio-pharmaceutical industry. Mr. Marcus served as the Vice Chairman and Chief Operating Officer of Alexandria Real Estate Equities Inc. from 1994 to 1997 and served as its Secretary from 1994 to April 1997. From 1984 to 1994, he also served as a General Counsel and Secretary at Kirin-Amgen, Inc. He was a practicing Certified Public Accountant and Tax Manager with Arthur Young & Co. focusing on the financing and taxation of REITs. He was one of the original architects of the Kirin-Amgen joint venture. He served as a Director of Lodo Therapeutics Corp. He serves as a Director of ApoGen Biotechnologies, Inc. He serves as Co-Founder, Chairman and Member of the Board of Directors & Observer at Alexandria AgTech Accelerator. Mr. Marcus serves as Member of the Board of Directors of The Scripps Research Institute (TSRI). He served as Director of Intra-Cellular Therapies, Inc. since April 2006 until April 02, 2025. He has been a Director of The Multiple Myeloma Research Foundation, Inc since April 4, 2013 and Foundation for the National Institutes of Health Inc. (FNIH) since May 16, 2012. Mr. Marcus serves as a Director of Reactive Biosciences Inc. (formerly known as Boragen Inc.). and the 9/11 Memorial & Museum. He was a Director of Rodeo Therapeutics Corp. until 2020. He serves as Board Observer of Imara, Inc. He serves as a Director of NYU Schack Institute of Real Estate, NewYorkB10, The Partnership for New York City, Inc. Robin Hood Foundation, NewYorkBIO, Friends of Cancer Research, Biotechnology Innovation Organization, CURE (Citizens United for Research in Epilepsy) and Accelerator Life Science Partners. He was a Director at Petra Pharma Corporation. He served as a Director of Proniras Corporation. Mr. Marcus serves as a Member of Advisory Board at QB3. He serves as a Member of Advisory Board at New York City Investment Fund Manager, Inc. and focuses on healthcare. He is also part of 2016 NAREIT Advisory Board of Governors and NAREIT's 2017 Executive Board. He served as a Director of Boston Biomedical, Inc. and The Council for Entrepreneurial Development. He had been a Director of Atara Biotherapeutics, Inc. since November 2013 until March 29, 2019. Mr. Marcus served as a Director and Board Observer of Bay Area Bioscience Association. He served as a Director of BioRelix, Inc. and Yumanity Therapeutics, Inc. He served as a Director of Rexford Industrial Realty, Inc. from July 24, 2013 to January 9, 2015. He served as a Trustee of PennyMac Mortgage Investment Trust from August 2009 to August 7, 2012. He served as a Board Observer of VLST Corporation. He is the Chair of the Navy SEAL Foundation's 2017 New York City Benefit. Mr. Marcus is also The New York Academy of Sciences Economic Development for Science Award recipient for leadership in support of New York City as a center of scientific excellence. He is nationally recognized for his experience and expertise in strategic Partnering and was one of the original architects of the Kirin-Amgen joint venture. He was an Independent Director of Frequency Therapeutics Inc. since December 26, 2018 until May 05, 2023. He was named one of Real Estate Forum's 2017 Best Bosses in commercial real estate. He was a practicing C. P.A. specializing in the financing and taxation of real estate. Mr. Marcus holds a J. D. and B. A. from the University of California at Los Angeles.

Positions